Astorg acquires Hamilton Thorne and Cook Medical Reproductive Health

Astorg, a pan-European private equity firm, has announce the completion of its take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s Reproductive Health business.

Astorg will bring the two businesses together to create a new global ART MedTech company. A new brand identity for the combined business will be rolled out in 2025.

The combined business will serve customers in over 115 countries offering fertility clinics and IVF laboratories a comprehensive portfolio of high-quality and innovative products improving the outcomes and accessibility of fertility treatments globally.

“By the joining of forces of Hamilton Thorne and Cook Medical RH we are creating a unique, global, pure-play ART business at scale, with market leadership and an industry-leading product portfolio that is ideally positioned to address rising fertility challenges and better support fertility professionals and families on their fertility journeys,” said Olivier Lieven, managing director of Astorg.

“The Astorg Healthcare team will continue to leverage its strong track record in specialized MedTech and carve-out expertise to build a global leader in ART. We look forward to driving this next stage of growth, partnering closely with the combined business.”

To lead the combined global business into its next phase of growth, a new management team has been appointed.

Astorg, together with the new management team and all employees across the combined business, will support the delivery of innovative products and services to fertility clinics and IVF laboratories globally.

Wil Boren has been appointed as CEO and Jimmy DeStephens has been appointed as CFO and COO.

Tobias Nordblom, managing director of Astorg, commented: “We are delighted to welcome Wil as the new CEO of the combined business, along with Jimmy as CFO and COO.

“Wil’s impressive track record of leading, integrating and growing international MedTech businesses makes him uniquely positioned to lead the new company. We look forward to partnering with Wil, the leadership team and all employees across the combined business to create a global ART leader driven by innovation and supported by high quality products and a strong customer focus.”

Wil Boren, CEO, added: “Today marks a pivotal moment for Hamilton Thorne and Cook Medical RH and I am thrilled to lead the newly combined company, and I look forward to working with both teams joining forces. Hamilton Thorne and Cook Medical RH have impressive reputations, a broad range of innovative and quality-driven products, and outstanding customer service – a testament to the dedication and expertise of both teams.

“With our combined scope, expertise, and resources, we are uniquely positioned to help IVF clinics and patients, all with the goal of expanding access and improving fertility outcomes worldwide.”